Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal Disease [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating ferric citrate in subjects with hyperphosphatemia and end-stage renal disease (ESRD) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hyperphosphatemia

Drugs mentioned

• Ferric citrate (ferric citrate)

Snippet

Sponsor: Panion & BF Biotech Inc. | Conditions: Hyperphosphatemia, End Stage Renal Disease | Phase 3 | Status: COMPLETED